128
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

No Association Between Ct Value and COVID-19 Severity and Mortality in Qatar

, ORCID Icon, , , , , ORCID Icon, , & ORCID Icon show all
Pages 5323-5331 | Received 23 Jan 2023, Accepted 13 Jul 2023, Published online: 15 Nov 2023

References

  • Chivese T, Matizanadzo J, Musa O, et al. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis. Pathog Glob Health. 2022:1–13. doi:10.1080/20477724.2022.2029301
  • Goldman J, Robinson P, Uldrick T, Ljungman P. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer. 2021;9(6):e002630. doi:10.1136/jitc-2021-002630
  • Kahn F, Bonander C, Moghaddassi M, et al. Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden, July 2021 to January 2022. Eurosurveillance. 2022;27(9). doi:10.2807/1560-7917.es.2022.27.9.2200121
  • Incerti D, Rizzo S, Li X, et al. Prognostic model to identify and quantify risk factors for mortality among hospitalised patients with COVID-19 in the USA. BMJ Open. 2021;11(4):e047121. doi:10.1136/bmjopen-2020-047121
  • Rao S, Manissero D, Steele V, Pareja J. A narrative systematic review of the clinical utility of cycle Threshold values in the context of COVID-19. Infect Dis Ther. 2020;9(3):573–586. doi:10.1007/s40121-020-00324-3
  • Carter L, Garner L, Smoot J, et al. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 2020;6(5):591–605. doi:10.1021/acscentsci.0c00501
  • Magleby R, Westblade L, Trzebucki A, et al. Impact of severe acute respiratory syndrome coronavirus 2 viral load on risk of intubation and Mortality among hospitalized patients with coronavirus disease 2019. Clin Infect Dis. 2021;73(11):e4197–205.
  • Ramirez‐Hinojosa JP, Rodriguez‐Sanchez Y, Romero‐Gonzalez AK, et al. Association between cycle threshold (C t) values and clinical and laboratory data in inpatients with COVID‐19 and asymptomatic health workers. J Med Virol. 2021;93(10):5969–5976. doi:10.1002/jmv.27170
  • Waudby-West R, Parcell BJ, Palmer CN, Bell S, Chalmers JD, Siddiqui MK. The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort. Eur Respir J. 2021;58(1):2100360. doi:10.1183/13993003.00360-2021
  • Shah VP, Farah WH, Hill JC, et al. Association between SARS-CoV-2 cycle threshold values and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis. Open Forum Infect Dis. 2021;8(9). doi:10.1093/ofid/ofab453
  • Ade C, Pum J, Abele I, Raggub L, Bockmühl D, Zöllner B. Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study. J Clin Virol. 2021;138:104791. doi:10.1016/j.jcv.2021.104791
  • Aykac K, Cura Yayla BC, Ozsurekci Y, et al. The association of viral load and disease severity in children with COVID‐19. J Med Virol. 2021;93(5):3077–3083. doi:10.1002/jmv.26853
  • Karahasan Yagci A, Sarinoglu R, Bilgin H, et al. Relationship of the cycle threshold values of SARS-CoV-2 polymerase chain reaction and total severity score of computerized tomography in patients with COVID 19. Int J Infect Dis. 2020;101:160–166. doi:10.1016/j.ijid.2020.09.1449
  • Shah S, Singhal T, Davar N, Thakkar P. No correlation between Ct values and severity of disease or mortality in patients with COVID 19 disease. Indian J Med Microbiol. 2021;39(1):116–117. doi:10.1016/j.ijmmb.2020.10.021
  • Zhang N, Xie T, Ning W, He R, Zhu B, Mao Y. The severity of COVID-19 and its determinants: a systematic review and meta-analysis in China. Sustainability. 2021;13(9):5305. doi:10.3390/su13095305
  • Talukder A, Razu S, Alif S, Rahman M, Islam S. Association between symptoms and severity of disease in hospitalised novel coronavirus (COVID-19) patients: a systemic review and meta-analysis. J Multidiscip Healthc. 2020;15:1101–10.
  • Efeoglu Sacak M, Karacabey S, Sanri E, et al. Variables affecting mortality among COVID-19 patients with lung involvement admitted to the emergency department. Cureus. 2021. doi:10.7759/cureus.12559
  • Shi L, Wang Y, Wang Y, Duan G, Yang H. Dyspnoea rather than fever is a risk factor for predicting mortality in patients with COVID-19. J Infect. 2020;81(4):647–679. doi:10.1016/j.jinf.2020.05.013
  • Tré‐Hardy M, Wilmet A, Beukinga I, et al. Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies. J Med Virol. 2020;93(2):803–811. doi:10.1002/jmv.26303
  • Hayes L, Ingram J, Sculthorpe N. more than 100 persistent symptoms of SARS-CoV-2 (Long COVID): a scoping review. Front Med. 2021;8. doi:10.3389/fmed.2021.750378
  • Coyle PV, Al Molawi NH, Kacem MABH, et al. Reporting of RT-PCR cycle threshold (Ct) values during the first wave of COVID-19 in Qatar improved result interpretation in clinical and public health settings. J Med Microbiol. 2022;71(5). doi:10.1099/jmm.0.001499
  • Faíco-Filho K, Passarelli V, Bellei N. Is higher viral load in SARS-CoV-2 associated with death? Am J Trop Med Hyg. 2020;103(5):2019–2021. doi:10.4269/ajtmh.20-0954
  • Rajyalakshmi B, Reddy P, Reddy PR. Prognostic value of “cycle threshold” in confirmed COVID-19 patients. Indian J Crit Care Med. 2021;25(3):322–326. doi:10.5005/jp-journals-10071-23765
  • Rabaan A, Tirupathi R, Sule A, et al. Viral dynamics and real-time RT-PCR Ct values correlation with disease severity in COVID-19. Diagnostics. 2021;11(6):1091. doi:10.3390/diagnostics11061091
  • Jain V, Yuan J. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. 2020;65(5):533–546. doi:10.1007/s00038-020-01390-7
  • Li K, Wu J, Wu F, et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol. 2020;55(6):327–331. doi:10.1097/RLI.0000000000000672
  • Sürmeli A, Beyaz Ö, Sitre Koç E, Gündogdu Y, Çuhadaroglu Ç, Kocagöz S. Presenting characteristics and ICU admission among patients hospitalized with COVID-19. Infect Dis Clin Microbiol. 2021;3(1):14–21. doi:10.36519/idcm.2021.20
  • Zeng W, Qi K, Ye M, et al. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019. Eur J Gastroenterol Hepatol. 2022;34(2):168–76.
  • Shehab M, Alrashed F, Shuaibi S, Alajmi D, Barkun A. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis. BMJ Open Gastroenterol. 2021;8(1):e000571. doi:10.1136/bmjgast-2020-000571